Patient hematology during hospitalization for viral pneumonia caused by SARS-CoV-2 and non-SARS-CoV-2 agents: a retrospective studyResearch Published on 2021-05-142022-10-31 Journal: European Journal of Medical Research [Category] COVID-19, SARS, [키워드] acute respiratory syndrome Adenovirus adenovirus infection caused changes in Characteristics clinics coronavirus disease Course COVID-19 disease dynamic H1N1 hematological hematology hemoglobin Hospitalization influenza A neutrophil count occurred outbreak Pathogenesis Patient patients with SARS Pneumonia Prognosis respiratory virus Result retrospective Retrospective study SARS-CoV-2 severe COVID-19 single-center study thrombocytopenia Treatment Viral pneumonia was related [DOI] 10.1186/s40001-021-00515-9 PMC 바로가기 [Article Type] Research
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccinationPfizer 및 Moderna SARS-CoV-2 백신 접종 후 혈소판 감소증Article Published on 2021-05-012022-09-12 Journal: American journal of hematology [Category] 진단, [키워드] Moderna Pfizer SARS-CoV-2 vaccination thrombocytopenia [DOI] 10.1002/ajh.26132 PMC 바로가기 [Article Type] Article
COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodiesCOVID-19 환자는 종종 고역가의 비혈소판 활성화 항 PF4/헤파린 IgG 항체를 나타냅니다.Article Published on 2021-05-012022-09-11 Journal: Journal of thrombosis and haemostasis : JTH [Category] MERS, SARS, 진단, 치료기술, [키워드] activating Adverse reaction antibodies antibody Anticoagulants Antigen antigen tests caused clinically clinically suspected confirmation cornerstone COVID-19 COVID-19 patient COVID-19 patients COVID-19 sera Critically ill critically ill COVID-19 patients fraction functional functional test functional tests heparin heparin-induced thrombocytopenia HIPA IgG IgG antibody inhibit inhibitory investigated marker monoclonal antibody nine overdiagnosis overtreatment Platelet platelet activation platelet factor 4 Platelets positive purified reactivity remained sera serum serum/plasma tested thrombocytopenia thrombosis Treatment unlikely [DOI] 10.1111/jth.15262 PMC 바로가기 [Article Type] Article
Characteristics and outcomes of critically ill patients with covid-19 in Sakarya, Turkey: a single centre cohort study터키 사카리아의 코로나19 중증환자의 특성 및 결과: 단일 센터 코호트 연구Article Published on 2021-04-302022-09-10 Journal: Turkish Journal of Medical Sciences [Category] MERS, SARS, 치료제, [키워드] Acute kidney injury acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome acute respiratory syndrome coronavirus Admission admitted to ICU age ARDS Clinical outcome clinical outcomes cohort study Comorbidities consecutive patient coronavirus coronavirus disease Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) Critically ill Critically ill patient critically ill patients CRP CRP level CRP levels D-dimer demographic characteristics died dimer discharged elevated Final Follow-up high mortality rate hospital ICU ICUs intensive care unit intensive care units Laboratory lymphocytopenia material mechanical ventilation MODS Mortality MOST multiple organ dysfunction multiple organ dysfunction syndrome organ dysfunction syndrome outcome Patient patients Platelet Platelet count procalcitonin reported respiratory respiratory distress Result SARS-CoV-2 Serum ferritin severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) syndrome the patient thrombocytopenia training treatment protocols troponin troponin levels Turkey university [DOI] 10.3906/sag-2005-57 PMC 바로가기 [Article Type] Article
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021Full Report Published on 2021-04-302022-10-30 Journal: Morbidity and Mortality Weekly Report [Category] COVID-19, MERS, [키워드] Committee COVID-19 janssen Johnson & Johnson Practice recipient report thrombocytopenia United States [DOI] 10.15585/mmwr.mm7017e4 PMC 바로가기 [Article Type] Full Report
Diagnosis and management of coronavirus disease-associated immune thrombocytopenia: a case seriesCase Report Published on 2021-04-282022-10-28 Journal: Revista da Sociedade Brasileira de Medicina Tropic [Category] COVID-19, MERS, SARS, [키워드] association case sery Clinical course coronavirus coronavirus disease COVID-19 diagnosed disease-associated fatal complication Health immune Immune thrombocytopenia management Patient problem reported shown thrombocytopenia Treatment viral infections with COVID-19 [DOI] 10.1590/0037-8682-0029-2021 PMC 바로가기 [Article Type] Case Report
Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)사설: SARS-CoV-2 mRNA 백신과 백신 유발 면역 혈전성 혈소판 감소증(VITT)의 가능한 메커니즘Editorial Published on 2021-04-262022-09-11 Journal: Medical science monitor : international medical jo [Category] SARS, 유전자 메커니즘, 임상, [키워드] antibody AstraZeneca Autoimmune cavernous sinus cavernous sinus thrombosis ChAdOx1 ChAdOx1 nCoV-19 ChAdOx1 nCoV-19 vaccine clinical trials collaboration coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 cross-react death rate editorial Efficacy global pandemic heparin heparin-induced thrombocytopenia Hope morbidity mRNA mRNA vaccine Oxford Platelet platelet factor 4 Prevent safety profile SARS-CoV-2 SARS-CoV-2 spike Science Sinus thrombosis Spread syndrome the SARS-CoV-2 thrombocytopenia thrombosis thrombotic thrombotic event Thrombotic events University of Oxford vaccination virus women [DOI] 10.12659/MSM.932899 PMC 바로가기 [Article Type] Editorial
Bone Marrow and Peripheral Blood Findings in Patients Infected by SARS-CoV-2SARS-CoV-2에 감염된 환자의 골수 및 말초 혈액 소견Article Published on 2021-04-262022-08-31 Journal: American journal of clinical pathology [Category] MERS, 바이오마커, [키워드] 8 women Abnormalities abnormality acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Anemia Autopsy Blood bone Bone marrow calculated caused CBC clinical Coinfection coronavirus coronavirus disease coronavirus disease 19 COVID-19 Deceased Evidence evidence of examined finding hematologic Hematopoiesis Hemophagocytosis HLH immunohistochemical stains Laboratory Leukocytosis lymphopenia Marrow median men neutrophilic leukocytosis one patient Patient patients patients with COVID-19 peripheral Peripheral blood polycythemia ranged respiratory risk SARS-CoV-2 severe acute respiratory syndrome Coronavirus thrombocytopenia women [DOI] 10.1093/ajcp/aqaa274 PMC 바로가기 [Article Type] Article
Secondary Immune Thrombocytopenic Purpura Triggered by COVID-19Internal Medicine Published on 2021-04-152022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute respiratory syndrome Admission agonist bleeding cause coronavirus coronavirus disease Course COVID 19 COVID-19 Department described Dexamethasone discharge Donor Emergency Fibrinogen levels FIVE Hematuria Hispanic Immune thrombocytopenic purpura implicated intravenous Intravenous immunoglobulin Laboratory life-threatening limits male management Multiple normalized Pathogens PCR Peripheral blood Platelet polymerase chain positive receptor SARS-CoV-2 secondary sputum steroid the patient thrombocytopenia transfused treated [DOI] 10.7759/cureus.14505 PMC 바로가기 [Article Type] Internal Medicine
Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial경증 또는 중등도의 COVID-19 폐렴으로 입원한 환자를 위한 염증 신호 억제제(MATIS)의 다군 시험: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2021-04-122022-09-10 Journal: Trials [Category] 임상, [키워드] 24 hours accounted Administered age agreement All participants Allergic reactions approved baseline blind blinded Blinding block Breastfeeding Caregivers cell proliferation childbearing potential clinical clinical outcomes clinically suspected college comparator completion Compliance Concomitant medication Contraception Controlled trial coronavirus COVID-19 COVID-19 disease COVID-19 pneumonia CPAP CRP Data monitoring committee Day death defined Desaturation determine diagnosed disease disease severity dissemination dose drug ECMO effective Efficacy element English enrolment exclusion experimental arm experimental intervention facemask FOS fostamatinib generate GRADE grade 3 Graft graft-versus-host-disease hepatic dysfunction hospital Hospital admission Hospital stay hospitalisation hospitalised patient Hospitalised patients Immune thrombocytopenia Imperial College Healthcare NHS Trust incidence information Informed consent inhibitor Inpatient Inpatients Intervention invasive Invasive mechanical ventilation invasive ventilation investigational agent investigator JAK1 JAK2 janus kinase Kinase inhibitor kinases Laboratory male participants MATIS Mild minimum moderate Moderate COVID-19 moderate to severe Modification multi-arm myelofibrosis nasal oxygen NHS Non-invasive non-invasive ventilation number objective Obstructive obstructive sleep apnoea opinion Ordinal Scale outcome oxygen Pairwise comparison pandemic parallel-group participant Patient Pneumonia polycythaemia vera principal investigator product progression promise proportion protocol random randomisation randomised randomised controlled trial receiving recruit recruited reduce reduce mortality reducing renal impairment renal replacement therapy replacement therapy required Requirement ruxolitinib Sample size sample size calculation Sample size calculations SARS-CoV2 infection scale Secondary objectives selective sequence severe allergic reaction Severe COVID-19 pneumonia severity severity of COVID-19 sexual intercourse signal sleep apnoea Sperm sperm donation spleen Splenomegaly Stage stage 2 Standard Standard of care statistical analysis status Stratification study drug Study protocol supplementary material Symptom systemic inflammation the WHO therapy thrombocytopenia translation Treatment Trial Trial registration Trust tyrosine tyrosine kinase inhibitor Venous Thromboembolism verbal website WHO with COVID-19 [DOI] 10.1186/s13063-021-05190-z PMC 바로가기 [Article Type] Letter